A Randomized Double-Blind Study of Alpha-Difluromethylornithine (DFMO) Versus Placebo in Patients With Cervical Intraepithelial Neoplasia (CIN) Grade 2-3
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Eflornithine (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia
- Focus Biomarker; Therapeutic Use
- 25 Oct 2018 Biomarkers information updated
- 17 Sep 2005 New trial record.